Immunogenicity and Safety of Comvigen (Bivalent) Vaccine

Clinical trial NCT05930730 · UNKNOWN

Trial details

NCT number: NCT05930730
Sponsor: Chulalongkorn University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Safety of a Single Dose of COMVIGEN Vaccine Reactogenicity of a Single Dose of COMVIGEN Vaccine Immunogenicity of a Single Dose of COMVIGEN Vaccine Safety of a Single Dose of BIVALENT Pfizer/BNT Vaccine Reactogenicity of a Single Dose of BIVALENT Pfizer/BNT Vaccine Immunogenicity of a Single Dose of BIVALENT Pfizer/BNT Vaccine

Start date: 2023-10-09
Primary completion: 2024-02-01
Enrollment: 450

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.